Literature DB >> 24243732

Direct visualization of hepatitis C virus-infected Huh7.5 cells with a high titre of infectious chimeric JFH1-EGFP reporter virus in three-dimensional Matrigel cell cultures.

Shuanghu Liu1, Ren Chen1, Curt H Hagedorn2,1.   

Abstract

Identification of the hepatitis C virus (HCV) JFH1 isolate enabled the development of infectious HCV cell culture systems. However, the relatively low virus titres and instability of some chimeric JFH1 reporter viruses restricts some uses of this system. We describe a higher-titre JFH1-EGFP reporter virus where the NS5A V3 region was replaced with the EGFP gene and adapted by serial passage in Huh7.5 cells. Six adaptive mutants were identified: one each in E2, P7 and NS4B, plus three in the NS5A region. These adaptive mutants increased the reporter virus titres to 1×10(6) immunofluorescent focus-forming units ml(-1), which is the highest titre of JFH1-EGFP reporter virus reported to our knowledge. This chimeric virus did not lose EGFP expression following 40 days of passage and it can be used to test the activity of HCV antivirals by measuring EGFP fluorescence in 96-well plates. Moreover, this reporter virus allows living infected Huh7.5 cells in Matrigel three-dimensional (3D) cultures to be visualized and produces infectious viral particles in these 3D cultures. The chimeric NS5A-EGFP infectious JFH1 reporter virus described should enable new studies of the HCV life cycle in 3D cell cultures and will be useful in identifying antivirals that interfere with HCV release or entry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24243732      PMCID: PMC3917068          DOI: 10.1099/vir.0.055772-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  42 in total

1.  Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes.

Authors:  Tung Phan; Rudolf K F Beran; Christopher Peters; Ivo C Lorenz; Brett D Lindenbach
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

2.  Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.

Authors:  Zhaohui Cai; Chen Zhang; Kyung-Soo Chang; Jieyun Jiang; Byung-Chul Ahn; Takaji Wakita; T Jake Liang; Guangxiang Luo
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Robust hepatitis C virus infection in vitro.

Authors:  Jin Zhong; Pablo Gastaminza; Guofeng Cheng; Sharookh Kapadia; Takanobu Kato; Dennis R Burton; Stefan F Wieland; Susan L Uprichard; Takaji Wakita; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

Review 4.  The changing epidemiology and natural history of hepatitis C virus infection.

Authors:  Stephanie R Bialek; Norah A Terrault
Journal:  Clin Liver Dis       Date:  2006-11       Impact factor: 6.126

5.  A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses.

Authors:  Ville Härmä; Johannes Virtanen; Rami Mäkelä; Antti Happonen; John-Patrick Mpindi; Matias Knuuttila; Pekka Kohonen; Jyrki Lötjönen; Olli Kallioniemi; Matthias Nees
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

6.  Monitoring the antiviral effect of alpha interferon on individual cells.

Authors:  Chon Saeng Kim; Jong Ha Jung; Takaji Wakita; Seung Kew Yoon; Sung Key Jang
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

7.  The NS5A protein of hepatitis C virus is a zinc metalloprotein.

Authors:  Timothy L Tellinghuisen; Joseph Marcotrigiano; Alexander E Gorbalenya; Charles M Rice
Journal:  J Biol Chem       Date:  2004-08-31       Impact factor: 5.157

8.  Complete replication of hepatitis C virus in cell culture.

Authors:  Brett D Lindenbach; Matthew J Evans; Andrew J Syder; Benno Wölk; Timothy L Tellinghuisen; Christopher C Liu; Toshiaki Maruyama; Richard O Hynes; Dennis R Burton; Jane A McKeating; Charles M Rice
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728

9.  Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain.

Authors:  Nicole Appel; Thomas Pietschmann; Ralf Bartenschlager
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

10.  Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Anne B Eldrup; Charles R Allerson; C Frank Bennett; Sanjib Bera; Balkrishen Bhat; Neelima Bhat; Michele R Bosserman; Jennifer Brooks; Christine Burlein; Steven S Carroll; P Dan Cook; Krista L Getty; Malcolm MacCoss; Daniel R McMasters; David B Olsen; Thazha P Prakash; Marija Prhavc; Quanlai Song; Joanne E Tomassini; Jie Xia
Journal:  J Med Chem       Date:  2004-04-22       Impact factor: 7.446

View more
  10 in total

1.  Knockdown of Autophagy Inhibits Infectious Hepatitis C Virus Release by the Exosomal Pathway.

Authors:  Shubham Shrivastava; Pradip Devhare; Nanthiya Sujijantarat; Robert Steele; Young-Chan Kwon; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

2.  Tannic Acid Inhibits Hepatitis C Virus Entry into Huh7.5 Cells.

Authors:  Shuanghu Liu; Ren Chen; Curt H Hagedorn
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

Review 3.  Engineered Livers for Infectious Diseases.

Authors:  Nil Gural; Liliana Mancio-Silva; Jiang He; Sangeeta N Bhatia
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-11-22

4.  Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture.

Authors:  Yucel Aydin; Milad Chedid; Srinivas Chava; Donkita Danielle Williams; Shuanghu Liu; Curt H Hagedorn; Suchitra Sumitran-Holgersson; Krzysztof Reiss; Krzysztof Moroz; Hua Lu; Luis A Balart; Srikanta Dash
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

5.  Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release.

Authors:  Qi Wang; Yue Li; Shun-Ai Liu; Wen Xie; Jun Cheng
Journal:  World J Gastroenterol       Date:  2018-03-28       Impact factor: 5.742

6.  Adapted HCV JFH1 variant is capable of accommodating a large foreign gene insert and allows lower level HCV replication and viral production.

Authors:  Qi Wang; Curt Hagedorn; Shuanghu Liu
Journal:  Int J Biol Sci       Date:  2018-07-13       Impact factor: 6.580

7.  High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals.

Authors:  Anne F Pihl; Anna F Offersgaard; Christian K Mathiesen; Jannick Prentoe; Ulrik Fahnøe; Henrik Krarup; Jens Bukh; Judith M Gottwein
Journal:  Sci Rep       Date:  2018-11-30       Impact factor: 4.379

Review 8.  Three-dimensional cell culture models for investigating human viruses.

Authors:  Bing He; Guomin Chen; Yi Zeng
Journal:  Virol Sin       Date:  2016-10-27       Impact factor: 4.327

Review 9.  Three-Dimensional Cell Culture Systems for Studying Hepatitis C Virus.

Authors:  Chui-Wa So; Glenn Randall
Journal:  Viruses       Date:  2021-01-30       Impact factor: 5.048

10.  Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection.

Authors:  Keith Meyer; Young-Chan Kwon; Shuanghu Liu; Curt H Hagedorn; Ratna B Ray; Ranjit Ray
Journal:  Sci Rep       Date:  2015-03-11       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.